Gadobenate dimeglumine
Product Description
Biophore Pharma INC.
-
US
-
2015On CPHI since
-
3Certificates
Company types
Specifications
Biophore Pharma INC.
-
US
-
2015On CPHI since
-
3Certificates
Company types
More Products from Biophore Pharma INC. (57)
-
Product Levothyroxine Sodium
Levothyroxine Sodium is indicated for the treatment of Hypothyroidism, Pituitary TSH Suppression.
Biophore's Levothyroxine Sodium: Product meets USP & EP Specifications, Techpack Available -
Product Phytonadione
Phytonadione is an vitamin indicated for the treatment of Anticoagulant-Induced Prothrombin deficiency, Prophylaxis, Hypoprothrombinemia.
Biophore's Phytonadone: Product meets USP , EP and JP specifications, Completely synthetic product, Impurity profile as per ICH.
... -
Product Temozolamide
Temazolamide is used in the treatment of Anticancer.
Biophore's Temozolamide: Polymorphic form; Form III, Stringent control on genotoxic impurities, Product meets USP specificationsm, All impurities below 0.15, DMF has been reviewed and approved in Europe, Particle size requirement as per c... -
Product Zileuton
Zileuton is an NSAID, and Anti Asthama agent.
Biophore's Zileuton: USFDA approved manufacturing facility, DMF Number 26446, Completeness Assessment of the US DMF Complete. -
Product Diazoxide
Diazoxide is an Anti hypoglycemic agent.
-
Product Eliglustat
Eliglustat is an Endocrine-Metabolic Agent is indicated for the Long-term treatment of adult patients with Gaucher disease type 1.
Biophore's Eliglustat: Under development
-
Product Gadobutrol
Gadobutrol is an MRI Contrast Agent.
Biophore's Gadobutrol: Product meets the specifications of the EP draft monograph, All impurities below 0.05, Stringent control on sodium and chloride. -
Product Liothyronine Sodium
Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.
Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed
-
Product Methazolamide
Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
Biophore's Methazolamide: -
Product Nadolol
Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.
Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016. -
Product Palbociclib
Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2.
-
Product Sincalide
Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.
Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.
Biophore Pharma INC. resources (2)
-
Video Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023
Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023 -
Video BioPhore India Pharmaceuticals Pvt Ltd at CPHI Worldwide 2018
Dr. Jagadeesh Babu Ranglsetty, Founder & CEO of BioPhore India Pharmaceuticals Pvt. Ltd., speaks With CPHI TV at CPHI Worldwide in Madrid, Spain
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance